caloreen has been researched along with trinitrobenzenesulfonic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelnour, A; Chatelain, D; Dépeint, F; Deremaux, L; Dupas, JL; Madec, JY; Mazière, JC; Pouillart, PR; Saniez, MH; Vincent, O; Wils, D; Younes, H | 1 |
| Beghyn, T; Deprez, B; Desreumaux, P; Dubreuil, L; Dubuquoy, L; Flament, MP; Guerin-Deremaux, L; Karrout, Y; Moussa, E; Neut, C; Piveteau, C; Siepmann, F; Siepmann, J; Wils, D | 1 |
2 other study(ies) available for caloreen and trinitrobenzenesulfonic acid
| Article | Year |
|---|---|
Nutriose, a prebiotic low-digestible carbohydrate, stimulates gut mucosal immunity and prevents TNBS-induced colitis in piglets.
Topics: Animals; Animals, Newborn; Colitis; Dextrins; Dietary Carbohydrates; Enzyme-Linked Immunosorbent Assay; Immunity, Mucosal; Immunoglobulin A, Secretory; Immunomodulation; Intestinal Mucosa; Male; Prebiotics; Reverse Transcriptase Polymerase Chain Reaction; Swine; Trinitrobenzenesulfonic Acid | 2010 |
In vivo efficacy of microbiota-sensitive coatings for colon targeting: a promising tool for IBD therapy.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cellulose; Colitis; Colon; Dextrins; Drug Delivery Systems; Hydroxymethylglutaryl-CoA Synthase; Interleukin-1beta; Male; Mesalamine; Mice, Transgenic; Microbiota; Peroxidase; PPAR gamma; Rats, Wistar; RNA, Messenger; Starch; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2015 |